GRP
LRMR icon

Global Retirement Partners’s Larimar Therapeutics LRMR Stock Holding History

Global Retirement Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8K Buy
+1,247
New +$4.95K ﹤0.01% 3787
2025
Q4 		$6.37K Buy
1,673
+253
+18% +$984 ﹤0.01% 3348
2025
Q3 		$4.59K Buy
+1,420
New +$5.33K ﹤0.01% 3008
2022
Q4 		– Sell
-225
Closed -$1K – 3065
2022
Q3 		$1K Hold
225
– – ﹤0.01% 2506
2022
Q2 		$0 Hold
225
– – ﹤0.01% 2801
2022
Q1 		$1K Buy
+225
New +$1.47K ﹤0.01% 2446

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Global Retirement Partners's LRMR Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 1,247 shares worth $3.8K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in LRMR as recently as Q4 2025.

Global Retirement Partners first reported a position in LRMR in Q1 2022 and has held it in 6 quarters since. The position peaked at $6.37K in Q4 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Global Retirement Partners held 1,247 shares of Larimar Therapeutics worth $3.8K as of Q2 2026.
  • Larimar Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3787 holding.
  • Global Retirement Partners first reported a position in Larimar Therapeutics in Q1 2022 and has held it in 6 quarters since.
  • Global Retirement Partners's Larimar Therapeutics position peaked at $6.37K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.